![Dirk Kersten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Dirk Kersten is currently Director at NorthSea Therapeutics BV, Independent Director at Dyne Therapeutics, Inc. since 2018, Director at Synox Therapeutics Ltd., and Managing Partner at Forbion Capital Partners Management Holding BV since 2018.
Former positions include Director at GTx, Inc., Audion Therapeutics BV, Ascendis Pharma A, Profibrix BV (Director-Supervisory Board), NightBalance BV, Lanthio Pharma BV, and Non-Executive Director at ViCentra BV.
Mr. Kersten was Managing Director at INKEF Capital BV from 2014 to 2018 and Partner at Gilde Healthcare Partners, Inc. from 2011 to 2014.
Education includes graduate studies at the University of Groningen.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/11/2018 |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Inversor de Capital Privado | 01/10/2018 |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Director/Miembro de la Junta | - |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 01/09/2018 |
Gilde Healthcare Partners, Inc.
 Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Director Ejecutivo | 01/05/2014 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Director/Miembro de la Junta | - |
NightBalance BV
 NightBalance BV Medical DistributorsDistribution Services Develops and markets sensor-devices for the treatment of sleep apnea | Director/Miembro de la Junta | - |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Audion Therapeutics BV
 Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Discovers and deveops of drugs | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
NightBalance BV
NightBalance BV Medical DistributorsDistribution Services Develops and markets sensor-devices for the treatment of sleep apnea | Distribution Services |
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Health Technology |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
ViCentra BV
 ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
